Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Christopher Davis

机构：Herman Miller (United States), Indiana University School of Medicine, Indiana University – Purdue University Indianapolis · ORCID：0009-0004-7226-3819

发表论文 135 篇 · 总被引 827 次 · h-index 16

代表论文

  • Supplementary Table 9 from Combined Inhibition of HRAS and MEK Induces Tumor Regression and Restores Myogenic Differentiation in HRAS-Mutant Rhabdomyosarcoma (2026)
  • Supplementary Table 8 from Combined Inhibition of HRAS and MEK Induces Tumor Regression and Restores Myogenic Differentiation in HRAS-Mutant Rhabdomyosarcoma (2026)
  • Supplementary Table 8 from Combined Inhibition of HRAS and MEK Induces Tumor Regression and Restores Myogenic Differentiation in HRAS-Mutant Rhabdomyosarcoma (2026)
  • Supplementary Table 9 from Combined Inhibition of HRAS and MEK Induces Tumor Regression and Restores Myogenic Differentiation in HRAS-Mutant Rhabdomyosarcoma (2026)
  • Supp fig 2 from PLK1 Inhibition Induces Synthetic Lethality in Fanconi Anemia Pathway–Deficient Acute Myeloid Leukemia (2026)
  • Supp fig 7 from PLK1 Inhibition Induces Synthetic Lethality in Fanconi Anemia Pathway–Deficient Acute Myeloid Leukemia (2026)